• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Prefilled Syringes to 2022 - Product Image

Prefilled Syringes to 2022

  • ID: 3064189
  • January 2015
  • Region: Global
  • Greystone Associates

The administration of therapeutic drugs via injection is an indispensable delivery method for numerous drugs critical to patient health and well-being. Now this segment is evolving in response to changing patient populations, new classes of powerful therapeutic drugs and healthcare administration initiatives. Population demographics and efforts by managed care providers to control healthcare costs are driving the growth in drug self-administration, particularly for chronic conditions, introducing a new class of naïve users to parenteral drug delivery. For Fill-and-Finish contractors, market proximity is an important competitive factor. As the use of prefilled syringes continues to grow, the issue of prefilled syringe safety has received increased attention, with both integrated prefillable safety syringes and safety solutions designed to accommodate existing prefillable syringes advancing commercially. This report analyzes eleven important prefilled syringe therapeutic segments and examines key regulatory, economic and competitive factors that represent potential barriers to commercial success.

Highlights

- Provides detailed analysis of prefilled syringe market segments, market dynamics and market demographics

- Analyzes therapeutic demand drivers and evaluates commercial prefilled syringe products in eleven major therapeutic segments

- Examines design factors, material selection issues, technologies and market development issues

- Provides product data, market share, and forecasts to 2022

- Profiles injectable drug and device participants, their product development activities, business strategies, and corporate alliances and affiliations

Note: Product cover images may vary from those shown

1. Executive Summary

2. The Prefilled Device Landscape
- Evolving Device Technology
- Supply Chain Factors
- Industry Alignment
- Competitive Landscape
- Demand Drivers

3. Therapeutic Market Factors
- Drug Discovery and Development
- Diseases and Indications
- Patient Demographics
- Dosing Frequency and Safety
- Managed Care Initiatives

4. Prefilled Syringes: Design Factors
- Drug Stability and Shelf Life
- Material Selection Issues
- Point-of-Use Reconstitution
- Caregiver Safety
- Needle Configuration Strategies
- Human Engineering/Ergonomics

5. Prefilled Syringes: Commercial Devices
- Prefillable Therapeutic Injectables
- Glass Prefillable Syringes
- Plastic Prefillable Syringes
- Ready-to-Fill Safety Syringes

6. Specialty Prefillable Syringes
- Flush Syringes
- Diluent Syringes
- Imaging Agent Syringes

7. Prefilled Syringe Market Segments
- Anaphylaxis
- Anticoagulants
- Autoimmune Diseases
- Emergency Medicine
- Hepatitis
- Hematopoietics and Related Erythropoiesis Stimulating Proteins
- Metabolic Diseases
- Neurology
- Reproductive Health
- Vaccines

8. Non-API Prefilled Syringe Segments

9. Market Factors
- Self-Administration and Patient Compliance
- Regulatory Guidance and Product Approvals
- The Evolving PFS Ecosystem

10. Company Profiles

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Bayer AG LEO Laboratories Ltd. Grünenthal GmbH Medtronic, Inc. Teva Pharmaceutical Industries Ltd. Pall Corporation